Treace Medical Concepts, Inc. (TMCI) Financial Statements
Industry: Surgical & Medical Instruments & Apparatus
In fiscal 2025, Treace Medical Concepts reported revenue of $212.7M, up 1.6% from $209.4M the year before. Net income was -$59.0M (a -27.7% net margin), or -$0.93 per diluted share. Gross margin was 79.8% and operating margin was -25.5%. Operating activities generated -$16.0M of cash, leaving -$29.5M of free cash flow. At fiscal year end, Treace Medical Concepts held $190.6M in total assets against $103.2M in total liabilities, including $10.7M of cash and equivalents.
Open the full interactive Treace Medical Concepts financials → Quarterly statements, key ratios, valuation history and price charts.
Treace Medical Concepts Key Stats
| Share Price | $4.10 |
|---|---|
| Market Cap | $266.7M |
| Revenue YoY Growth | +1.6% |
| 52-Week Range | $1.20 – $6.95 |
| Shares Outstanding | 65.0 million (basic, 2026 Q2) |
Treace Medical Concepts Income Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $94.4M | $141.8M | $187.1M | $209.4M | $212.7M |
| Cost of Goods Sold | $17.8M | $27.5M | $35.2M | $41.1M | $42.9M |
| Gross Profit | $76.6M | $114.3M | $151.9M | $168.3M | $169.8M |
| Operating Income | -$16.5M | -$34.8M | -$51.4M | -$55.7M | -$54.2M |
| Pre-Tax Income | -$20.6M | -$42.8M | -$49.5M | -$55.7M | -$59.0M |
| Income Tax | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$20.6M | -$42.8M | -$49.5M | -$55.7M | -$59.0M |
| Diluted EPS | -$0.43 | -$0.77 | -$0.81 | -$0.90 | -$0.93 |
Treace Medical Concepts Quarterly Results
| 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | |
|---|---|---|---|---|
| Revenue | $50.2M | $62.5M | $47.2M | $45.4M |
| Net Income | -$16.3M | -$9.4M | -$18.0M | -$15.9M |
| Diluted EPS | -$0.26 | -$0.15 | -$0.28 | -$0.24 |
Treace Medical Concepts Balance Sheet
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash & Equivalents | $105.8M | $19.5M | $13.0M | $11.3M | $10.7M |
| Current Assets | $138.0M | $133.4M | $198.4M | $161.4M | $132.1M |
| Total Assets | $140.8M | $159.0M | $251.9M | $217.1M | $190.6M |
| Current Liabilities | $18.2M | $30.2M | $45.0M | $34.9M | $30.6M |
| Total Long-Term Debt | $29.4M | $52.7M | $53.0M | $53.3M | $55.6M |
| Total Liabilities | $47.7M | $98.5M | $114.0M | $104.2M | $103.2M |
| Shareholders' Equity | $93.1M | $60.5M | $137.9M | $112.9M | $87.3M |
Treace Medical Concepts Cash Flow Statement
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Cash From Operations | -$17.2M | -$30.6M | -$34.6M | -$37.2M | -$16.0M |
| Cash From Investing | -$2.7M | -$76.5M | -$81.3M | $35.4M | $13.3M |
| Cash From Financing | $107.7M | $20.8M | $109.4M | $160,000 | $2.1M |
| Free Cash Flow | -$19.9M | -$45.4M | -$46.0M | -$48.8M | -$29.5M |
Figures from Treace Medical Concepts' 10-K and 10-Q filings with the SEC, as of 2026-10-14. Fiscal years follow the company's own reporting calendar. EPS and share counts are adjusted for later stock splits. See the full Treace Medical Concepts financials page for every line item.
Treace Medical Concepts Company Profile
| Ticker | TMCI |
|---|---|
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Headquarters | Ponte Vedra, Florida |
| Incorporated in | Florida |
| Fiscal Year End | December 31 |
| SEC Filer Category | Accelerated filer |
| SEC CIK | 0001630627 |
Frequently Asked Questions
What was Treace Medical Concepts' revenue in fiscal 2025?
Treace Medical Concepts (TMCI) reported revenue of $212.7M for fiscal 2025.
What is Treace Medical Concepts' annual revenue history?
Treace Medical Concepts' annual revenue by fiscal year: 2021: $94.4M; 2022: $141.8M; 2023: $187.1M; 2024: $209.4M; 2025: $212.7M.
What was Treace Medical Concepts' net income in fiscal 2025?
Treace Medical Concepts reported net income of -$59.0M for fiscal 2025.
What was Treace Medical Concepts' earnings per share (EPS) in fiscal 2025?
Treace Medical Concepts' diluted EPS was -$0.93 for fiscal 2025 (adjusted for any later stock splits).
How much free cash flow did Treace Medical Concepts generate in fiscal 2025?
Treace Medical Concepts generated -$29.5M of free cash flow in fiscal 2025.
What was Treace Medical Concepts' revenue last quarter?
In its most recent reported quarter (2026 Q2), Treace Medical Concepts reported revenue of $45.4M.
How much debt does Treace Medical Concepts have?
Treace Medical Concepts reported $55.6M of long-term debt, including the current portion, at the end of fiscal 2025.
How many shares of Treace Medical Concepts are outstanding?
Treace Medical Concepts reported a weighted average of 65.0 million basic shares outstanding in 2026 Q2.
What is Treace Medical Concepts' market cap?
Based on its latest closing price, Treace Medical Concepts (TMCI) has a market capitalization of about $266.7M.
When does Treace Medical Concepts' fiscal year end?
Treace Medical Concepts' fiscal year end, as registered with the SEC, is December 31.
Where is Treace Medical Concepts headquartered?
Treace Medical Concepts lists its business address in Ponte Vedra, Florida in its SEC filings.
Treace Medical Concepts Competitors & Similar Companies
See all 109 Surgical & Medical Instruments & Apparatus companies →